Correlation Between Ventyx Biosciences and Mineralys Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Ventyx Biosciences and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ventyx Biosciences and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ventyx Biosciences and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Ventyx Biosciences and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ventyx Biosciences with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ventyx Biosciences and Mineralys Therapeutics,.

Diversification Opportunities for Ventyx Biosciences and Mineralys Therapeutics,

0.22

Correlation Coefficient

Ventyx Biosciences  Mineralys Therapeutics,

Modest diversification

The 3 months correlation between Ventyx and Mineralys is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Ventyx Biosciences and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Ventyx Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ventyx Biosciences are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Ventyx Biosciences i.e., Ventyx Biosciences and Mineralys Therapeutics, go up and down completely randomly.

Pair Corralation between Ventyx Biosciences and Mineralys Therapeutics,

Given the investment horizon of 90 days Ventyx Biosciences is expected to generate 1.18 times more return on investment than Mineralys Therapeutics,. However, Ventyx Biosciences is 1.18 times more volatile than Mineralys Therapeutics, Common. It trades about -0.1 of its potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about -0.25 per unit of risk. If you would invest  225.00  in Ventyx Biosciences on October 16, 2024 and sell it today you would lose (30.00) from holding Ventyx Biosciences or give up 13.33% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Ventyx Biosciences  vs.  Mineralys Therapeutics, Common

Ventyx Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ventyx Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Mineralys Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mineralys Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Ventyx Biosciences and Mineralys Therapeutics,

The main advantage of trading using opposite Ventyx Biosciences and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ventyx Biosciences position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.

The idea behind Ventyx Biosciences and Mineralys Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .